Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Contrast-Enhanced Mammography or Breast MRI: Which Choice for Optimal Diagnostic Performance?

NCT06843083 is registered in ClinicalTrials.gov with Graziella di Grezia as lead sponsor.

NCT NCT06843083
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06843083 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Contrast-Enhanced Mammography or Breast MRI: Which Choice for Optimal Diagnostic Performance?
Lead sponsor
Graziella di Grezia
Phase
Observational
Overall status
Enrolling by invitation
Start date
February 1, 2025
Completion date
January 31, 2026
Enrollment
350 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

breast cancer diagnosis, breast cancer prevention